Categories Uncategorized

Aspirin overcomes cisplatin resistance in lung cancer by inhibiting cancer cell stemness

Aspirin overcomes cisplatin resistance in lung cancer by inhibiting cancer cell stemness Introduction Lung cancer is the leading cause of cancer death with a less than 20% five‐year survival rate.1 Resistance to clinical integrated treatment is reported as one major reason for treatment failure.2 The standard treatment of lung cancer is plain‐based combination chemotherapy.3 Cisplatin […]

Read More
Categories Cancer

September is National Childhood Cancer Awareness Month

September is National Childhood Cancer Awareness Month .@CHBlades, Sr. VP Chief #ESG and Comms Officer @Aflac discuss National Childhood Cancer Awareness Month and how My Special Aflac Duck® is helping children with cancer cope during further isolation from COVID-19. https://bit.ly/3i0yAWG @ATLPedsHemOnc via @wpri12 Published at Tue, 29 Sep 2020 22:30:50 +0000

Read More
Categories Multiple Myeloma

Multiple Myeloma Update: Frontline Therapy

Multiple Myeloma Update: Frontline Therapy Earn CME: https://naccme.com/program/7328 In this presentation from the ‘Updates on Treatment Approaches Across the Multiple Myeloma Spectrum’ symposium at the 2019 Great Debates & Updates in Hematologic Malignancies in New York, Dr. Jonathan L. Kaufman provides an update on first line therapy for multiple myeloma. © 2019 Imedex, an HMP […]

Read More
Categories Cancer

Blocking nuclear pore complex formation can help selectively kill cancer cells

Blocking nuclear pore complex formation can help selectively kill cancer cells Reviewed by Emily Henderson, B.Sc.Sep 28 2020 Scientists at Sanford Burnham Prebys Medical Discovery Institute have shown that blocking the construction of nuclear pores complexes–large channels that control the flow of materials in and out of the cell nucleus–shrank aggressive tumors in mice while […]

Read More